[증시키워드] Expectations for Hyundai Motor and Apple EV cooperation continue Celltrion antibody treatment cruise

The keywords for the stock market on the 12th are #Samsung Electronics #Hyundai Motors #Kakao #Celltrion Healthcare #Celltrion.

Samsung Electronics, which settled at KRW 90,000 the previous day, introduced new technologies and services that will lead the era of’new normal’ brought by Corona 19 (new coronavirus infection) at CES 2021, the world’s largest electronics and IT exhibition, which opened online on the 11th (U.S. local time). Presented.

The first robot vacuum cleaner,’Samsung Jetbot AI’, was the first in the world to be equipped with an artificial intelligence (AI) solution from Intel. Through advanced object recognition technology, it self-recognizes surrounding objects and drives autonomously to find the optimal path.

Hyundai Motors surged for the second day in discussions on electric vehicle cooperation with Apple. While Apple is known to have consultations with several global automakers, including Hyundai Motors, with the aim of producing self-driving cars by 2024, Hyundai Motor Company said, “We are receiving requests for cooperation in joint development of self-driving electric vehicles from a number of companies. It has not been decided.” Expectations for cooperation with Apple are driving supply and demand.

Kakao is attracting attention as an analysis that the earnings surprise that lasted until the third quarter of last year is highly likely to be realized in the fourth quarter. Lee Min-ah, a researcher at Daishin Securities, said, “As most businesses enter the peak season, sales growth is very solid.” ”Analyzed.

Celltrion and Celltrion Healthcare are drawing attention from the market due to the anticipation of developing an antibody treatment for the novel coronavirus infection (Corona 19).

The previous day, the Ministry of Food and Drug Safety announced the progress of product approval for the Corona 19 antibody treatment and AstraZeneca vaccine. According to the Ministry of Food and Drug Safety, an investigation into the clinical trial agency (medical institution) will be conducted this week to confirm compliance with regulations throughout the clinical trials, such as the safety of clinical trial subjects and reliability of test results.

At the beginning of next week, a review meeting of the’Corona 19 vaccine/treatment safety/effectiveness verification advisory group’ will be held.